Why investors shouldn’t rush to buy the next blockbuster IPO

cityam08-26

IPOs get investors frothing at the mouth, yet the evidence suggests they should be viewed with greater caution, writes Yves BonzonThere are very few financial events which generate such excitement as ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2662762617?lang=en_US&edition=fundamental","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/08/SpaceX-IPO-e1787676078101.jpg?w=824&h=463&crop=1","is_english":true,"pubTime":"2026-08-26 11:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662762617","market":"nz","top_or_hot":-1,"title":"Why investors shouldn’t rush to buy the next blockbuster IPO","media":"cityam","content":"<div>\n<p>IPOs get investors frothing at the mouth, yet the evidence suggests they should be viewed with greater caution, writes Yves BonzonThere are very few financial events which generate such excitement as ...</p>\n\n<a href=\"https://www.cityam.com/why-investors-shouldnt-rush-to-buy-the-next-blockbuster-ipo/\">Source Link</a>\n\n</div>\n","source":"cityam_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why investors shouldn’t rush to buy the next blockbuster IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy investors shouldn’t rush to buy the next blockbuster IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-26 11:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cityam.com/why-investors-shouldnt-rush-to-buy-the-next-blockbuster-ipo/><strong>cityam</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IPOs get investors frothing at the mouth, yet the evidence suggests they should be viewed with greater caution, writes Yves BonzonThere are very few financial events which generate such excitement as ...</p>\n\n<a href=\"https://www.cityam.com/why-investors-shouldnt-rush-to-buy-the-next-blockbuster-ipo/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FRHC","symbol_name":"Euronext CAC Health Care","start_time":0,"source_url":"https://www.cityam.com/why-investors-shouldnt-rush-to-buy-the-next-blockbuster-ipo/","article_id":"2662762617","we_media_id":null,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/08/SpaceX-IPO-e1787676078101.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/why-investors-shouldnt-rush-to-buy-the-next-blockbuster-ipo/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662762617","pubTimestamp":1787716680,"columns":[],"sourceInfo":{"source_id":"cityam_highlight","name":"cityam"},"weMediaInfo":null,"summary":"IPOs get investors frothing at the mouth, yet the evidence suggests they should be viewed with greater caution, writes Yves BonzonThere are very few financial events which generate such excitement as initial public offerings  do. And yet history shows that they must be viewed with caution. When stepping back from and looking at what decades of empirical research tell us about investing in IPOs, the evidence is remarkably consistent and sobering.The first well-known stylised fact is IPO underpricing. On average, US IPOs have delivered a first-day return of roughly 18 to 19 per cent since 1980, according to latest data compiled by Jay Ritter of the University of Florida. But this ‘money left on the table’ accrues largely to those who receive an allocation at the offer price – who are typically institutional investors linked to the underwriting syndicate – rather than those buying once shares begin trading.Private vs public If the average public market investor is str","collect":0,"end_time":0,"defaultTopTitle":"cityam.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"FRHC":"Euronext CAC Health Care","BK4127":"投资银行业与经纪业","IPOS":"Renaissance International IPO ETF","REDS":"RPM Republican Senate ETF","KCE":"SPDR KBW Capital Markets ETF","IPO":"Renaissance IPO ETF"},"translate_title":"为什么投资者不应急于购买下一个重磅IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FRHC":1.5,"KCE":1.5,"REDS":1.5,"IPOS":1.5,"IPO":0.82},"content_text":"IPOs get investors frothing at the mouth, yet the evidence suggests they should be viewed with greater caution, writes Yves BonzonThere are very few financial events which generate such excitement as initial public offerings (IPOs) do. And yet history shows that they must be viewed with caution. When stepping back from and looking at what decades of empirical research tell us about investing in IPOs, the evidence is remarkably consistent and sobering. The first well-known stylised fact is IPO underpricing. On average, US IPOs have delivered a first-day return of roughly 18 to 19 per cent since 1980, according to latest data compiled by Jay Ritter of the University of Florida. But this ‘money left on the table’ accrues largely to those who receive an allocation at the offer price – who are typically institutional investors linked to the underwriting syndicate – rather than those buying once shares begin trading.\n\nSecuring an allocation is also no guarantee for investment success. Allocations in blockbuster deals are heavily rationed, while weak deals are typically readily available – the classic winner’s curse. As a result, an investment strategy that indiscriminately subscribes to IPOs is bound to earn far less than the headline first-day pops reported in IPO studies.Patience is a virtueNewly listed companies can also struggle to maintain their early momentum. Ritter found that IPOs significantly underperformed comparable firms in the first few years after listing, although much of this underperformance is concentrated among smaller, unprofitable companies. The pattern seems to be closely linked to market timing. Companies are skilled at issuing shares when investor enthusiasm, and valuations, are close to their peak. This aligns with one of our longest-standing investment convictions that valuation levels only matter in rare moments when they reach extremes, changing the reaction function of corporate issuers.\n\n\n\n\n\n\nNews Updates\nStay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAll in all, the empirical record suggests that patient investors are usually offered better entry points in the quarters following a listing than in the euphoric opening days. Of course, this does not mean investors should avoid IPOs altogether. Every great public company was once an IPO, and some of tomorrow’s biggest winners are undoubtedly listing today. The lesson is one of patience and discipline. Lock-up expiries can offer a useful moment to reassess the prevailing sentiment towards newly listed companies. As insider selling restrictions are lifted and more shares become available for trading, the market must absorb the additional equity supply. Without a corresponding increase in demand, this incremental supply can exert additional mechanical downward pressure on share prices.\n\nPrivate vs public If the average public market investor is structurally late to the party, why not simply join it earlier and participate while these companies are still private? While history shows that each generation of founders and venture capitalists has learned to stay private longer and harvest more of the value-creation curve before an IPO, this does not automatically render private market investments more attractive. In fact, venture capital returns are extraordinarily skewed towards the earliest funding rounds. The steepest portion of the value-creation curve accrues to investors willing to bear the highest mortality risk, at a stage where access is limited and identifying the eventual outliers with any meaningful degree of certainty is exceedingly difficult.For most investors, the key is therefore not to choose between private and public markets. One should remain disciplined in both. Private markets can offer attractive opportunities, particularly through experienced managers with access to promising companies at earlier stages of development. But a pre-IPO label does not automatically translate into superior returns; access, manager selection and valuation matter just as much as they do in public markets.Ultimately, investors cannot afford to miss the big winners in public markets. The objective is to participate in the long-term growth of exceptional businesses, not to gain access to them at the earliest possible stage. There is no need to secure a pre-IPO or IPO allocation at any price. Instead, investors can afford to be patient and build positions once the initial IPO volatility has subsided, while much of the company’s long-term compounding potential remains unrealised. \n\nYves Bonzon is group chief investment officer at Julius Baer","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2662762617","isCrawlerRequest":true}